Evonik and Higuchi strengthen oral drug delivery innovation in Japan with new joint laboratory
Germany, April 27 -- Evonik and Higuchi Inc., a leading Japanese trading company in the pharmaceutical sector, are opening a joint laboratory located in Yokohama, Japan. The "Open Pharma Lab" provides local formulators with hands?on access to Evonik's EUDRAGIT(R) polymers and broader system solutions expertise, supporting the growing demand for robust, patient?centric oral dosage forms. The new lab - open from May 1 - also expands Evonik's regional innovation network across Asia.EUDRAGIT(R) polymers are among the most established excipient technologies for oral drug delivery. Known for their versatility and regulatory acceptance, they enable precise control of release profiles while supporting the design of stable, patient?friendly solid do...
To read the full article or to get the complete feed from this publication, please
Contact Us.